Moreover, as a novel drug for the treatment of Parkinson's disease, naringin activates antiapoptotic programs by inducing the production of neurotrophic substances such as BDNF and vascular endothelial growth factor [30]. The gene discussed is VEGFA; the disease is Parkinson disease.